Over the past 12‑18 months the Hard Gelatin Capsules market has accelerated through a series of strategic moves and regulatory shifts. In Q2 2023, CapsuleCo entered a global partnership with EuroPharm to co‑develop pediatric‑friendly gelatin formulations, expanding distribution across Europe and Asia. The same year, PharmaTech acquired BioCapsule Ltd. for $210 million, adding a patented moisture‑control technology that shortens drying time by 30 %. Early 2024 saw the launch of EcoShell™, a plant‑based hard capsule line that incorporates a novel cross‑linking process, positioning it for the growing clean-label demand. The European Medicines Agency updated its monograph, allowing up to 5 % glycerol as a plasticizer, which broadens formulation flexibility for manufacturers. Meanwhile, consumer surveys indicate a 22 % rise in preference for “natural‑origin” capsules, prompting contract manufacturers to upscale clean‑room capacity. Finally, VentureCap completed a $45 million Series B round for CapsuLab, earmarked for scaling its continuous‑flow coating line, signaling confidence in long‑term capacity expansion. These Hard Gelatin Capsules industry trends suggest a trajectory toward higher sustainability, faster production cycles, and tighter regulatory alignment.
